3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Lung Neoplasms
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
Surveys and Questionnaires
18
Blood Specimen Collection
16
Specimen Handling
12
Observation
6
Magnetic Resonance Spectroscopy
6
Surgical Procedures, Operative
5
Radiotherapy
5
trastuzumab deruxtecan
4
ribociclib
4
darolutamide
4
Standard of Care
4
Patient Reported Outcome Measures
4
Letrozole
4
Data Collection
4
Cryosurgery
4
Breath Tests
4
Tomography, X-Ray Computed
3
Radiation
3
Neoadjuvant Therapy
3
Magnetic Resonance Imaging
3
Biopsy
3
Anastrozole
3
lorlatinib
2
cemiplimab
2
atezolizumab
2
Ultrasonography
2
Trastuzumab
2
Staining and Labeling
2
Restraint, Physical
2
Positron-Emission Tomography
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Radionuclide Imaging
×
30 days
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled